{"id":"W4366831744","doi":"10.1093/rheumatology/kead104.228","title":"P187 Safety and efficacy of ixekizumab treatment in patients with axial spondyloarthritis: 3-year results from the COAST programme","year":2023,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"UCB Pharma; Biogen; Eli Lilly and Company; Pfizer; National Psoriasis Foundation; Amgen","keywords":"Ixekizumab; Medicine; Placebo; Internal medicine; Secukinumab; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002159236,0.0005124398,0.001050324,0.0002121093,0.0003280471,0.0007774638,0.0004250659,0.0006425318,0.002560606],"category_scores_gemma":[0.001649439,0.000219927,0.001788703,0.0003066273,0.0004327911,0.0006263353,0.0005814531,0.001710671,0.0007099528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000555967,"about_ca_system_score_gemma":0.0009385492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009731844,"about_ca_topic_score_gemma":0.0014711,"domain_scores_codex":[0.9991435,0.0004188275,0.00006817933,0.000112341,0.0001339348,0.0001232749],"domain_scores_gemma":[0.9986132,0.0002540222,0.0004218339,0.0001147716,0.0002297528,0.0003663576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5854906,0.02059403,0.07664619,0.001603678,0.002569797,0.0005911227,0.0005448736,0.00230565,0.02439821,0.0002251706,0.01296432,0.2720662],"study_design_scores_gemma":[0.1476895,0.6254965,0.2021253,0.0002479448,0.002391938,0.0009119351,0.0003187588,0.001563057,0.007331459,0.0001932561,0.01166015,0.00007018582],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901071,0.00507124,0.0003588904,0.000393848,0.00007164814,0.0004257956,0.001658437,0.00004646702,0.001866538],"genre_scores_gemma":[0.991968,0.002009062,0.0006654899,0.0003953455,0.0001826569,0.0003518812,0.003001272,0.00002231092,0.001403951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002560606,"threshold_uncertainty_score":0.0114193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1231506825119348,"score_gpt":0.3344935237765945,"score_spread":0.2113428412646597,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}